Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Andexxa Lawsuit Andexxa recall lawsuits are being investigated after the FDA linked the drug to an increased risk of thrombotic events, including stroke, heart attack, pulmonary embolism, and fatal blood clots.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Unneeded Diagnostic Imaging Remains a Substantial Problem in U.S.: Report January 10, 2019 Martha Garcia Add Your Comments Medically unnecessary imaging tests remain a much more common problem in the United States, when compared to other countries, according to the findings of new research. In recent years, the healthcare industry has taken steps to help curb unneeded diagnostic imaging, including magnetic resonance imaging (MRI) and computed tomography (CT). However, the tests are still widely overused and researchers from the Mayo Clinic and Stanford Cancer Institute indicate that additional steps need to be taken to help reduce the practice. In the United States, CT scans are conducted five times more frequently than in Finland, and MRI scans are conducted three times more often, according to findings published this week in an editorial in the Journal for the American Medical Association (JAMA). Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The researchers indicate that aggressive testing only provides marginally more useful information. In addition, lead author Dr. John P.A. Ionnidis warns that diagnostic tests often detect “incidental” findings, which require further testing, evaluation, and treatment, but often don’t result in serious diagnoses. Ionnidis is based at the Stanford Prevention Research Center in California. He is calling for new strategies which include educating patients, focusing on only the target being examined, not the whole body, and involving radiologists as “gatekeepers.” The researchers noted that doctors should do a better job of explaining the risks involved with diagnostic testing. This may include radiation exposure, intravenous contrast risks, and the possibility of incidental findings that are not risky to the patient’s health. Doctors can begin to create a shared-decision making process with their patient to create transparency and decrease confusion about risks, treatment, and follow-up, they wrote. A recent study found that many patients are unaware of the true risks of radiation exposure from CT scans and MRIs. Roughly 22 percent of patients fully understood what ionizing radiation was and its potential impact on a person’s health. This may lead more patients to request or insist on unnecessary diagnostic imaging when the doctor has not called for it. Furthermore, they recommend that imaging tests only focus on the target area in question. This would call for radiologists to lower the image sensitivity for parts of the body that are not the focus of the testing. For example, if the breast is the focus of the test, scanning of the gut or other areas should be reduced. This can lead to fewer unnecessary diagnoses and treatments. While it doesn’t reduce the number of new unnecessary tests, it may prevent extra tests, they said. A study published in 2018 indicated the increased push for cancer screenings has resulted in the over diagnosis of more harmless cancers. Many of the cancers found are small tumors that would not grow and pose a risk to the patient’s health or would go away on their own. Yet, the push for screening results in the detection of cancers that are leading to unnecessary diagnostic screenings and treatments. The analysis also indicated, as diagnostic testing has become more enhanced allowing doctors to catch some cancers early, it may reduce the need for radiologists to read and interpret the results. Thus, radiologists could be trained as “gatekeepers” for diagnostic testing. In this way, they can regulate what tests are necessary and should be ordered or not ordered, instead of leaving it at the doctor’s discretion. Unnecessary diagnostic imaging can lead to unnecessary treatment. One-third of all breast cancer patients receive treatments that are not needed. This results in more than $4 billion spent each year on unnecessary healthcare costs, including unnecessary diagnostic testing and over-treatment. “Overuse of imaging equates to haphazard screening of individuals for disease,” the researchers wrote. “There is virtually no evidence that screening of this kind improves overall population health.” Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: CT Scan, Hospital, MRI, Radiation Exposure Image Credit: | More Lawsuit Stories Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 December 23, 2025 Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 December 23, 2025 Hyundai Seat Collapse Lawsuit Filed Over Severe Spinal Injury in Rear-End Accident December 23, 2025 0 Comments CommentsThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 3 days ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025) Amazon Fire Pit Lawsuit Set For Trial in February 2027 (Posted: 4 days ago) A federal judge has set a February 2027 trial date for an Amazon fire pit lawsuit alleging that a teenager suffered severe burn injuries after a relative attempted to relight the device. MORE ABOUT: TABLETOP FIRE PIT LAWSUITFamily Dollar, Amazon Face Lawsuit Over Tabletop Fire Pit Burn Injuries (12/03/2025)Amazon Space Heater Lawsuit Claims Defective Device Caused First Degree Burns (11/24/2025)Amazon Tabletop Fire Pit Fuel Recall Issued Due to “Deadly Risk of Flash Fire”: CPSC (11/21/2025) Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 1 week ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)
Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 December 23, 2025
Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 3 days ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)
Amazon Fire Pit Lawsuit Set For Trial in February 2027 (Posted: 4 days ago) A federal judge has set a February 2027 trial date for an Amazon fire pit lawsuit alleging that a teenager suffered severe burn injuries after a relative attempted to relight the device. MORE ABOUT: TABLETOP FIRE PIT LAWSUITFamily Dollar, Amazon Face Lawsuit Over Tabletop Fire Pit Burn Injuries (12/03/2025)Amazon Space Heater Lawsuit Claims Defective Device Caused First Degree Burns (11/24/2025)Amazon Tabletop Fire Pit Fuel Recall Issued Due to “Deadly Risk of Flash Fire”: CPSC (11/21/2025)
Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 1 week ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)